PL
Polaryx Therapeutics, Inc. Common Stock (PLYX)
NASDAQ·Healthcare·Biotechnology
$2.11
-2.09%
Mkt Cap $240.03M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$7.00
Range $7.00 – $7.00
Implied Upside
+232.5%
Consensus $7.00 vs current $2.11